04/16/2024 3:16 PM | ADC Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024 3:06 PM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/15/2024 3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/14/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
|
03/13/2024 3:17 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024 3:14 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024 2:19 PM | ADC Therapeutics (Filer)
| Form ARS | |
03/13/2024 11:25 AM | ADC Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/13/2024 6:39 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 8:15 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 8:47 AM | ADC Therapeutics (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
02/12/2024 9:13 AM | ADC Therapeutics (Subject) ASTRAZENECA PLC (Filed by) ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/09/2024 8:50 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 8:45 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/24/2024 7:00 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:30 PM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:15 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:00 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 7:00 PM | ADC Therapeutics (Issuer) Pfisterer Thomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:01 PM | ADC Therapeutics (Issuer) Sandor Victor (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:02 PM | ADC Therapeutics (Issuer) Squarer Ron (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:04 PM | ADC Therapeutics (Issuer) Hug Peter (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:05 PM | ADC Therapeutics (Issuer) Zaki Mohamed (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:06 PM | ADC Therapeutics (Issuer) Azelby Robert (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:07 PM | ADC Therapeutics (Issuer) BIZZARI JEAN-PIERRE (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:08 PM | ADC Therapeutics (Issuer) GRAHAM PETER J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:09 PM | ADC Therapeutics (Issuer) Carmona Jose (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:10 PM | ADC Therapeutics (Issuer) Monges Viviane (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 6:56 PM | ADC Therapeutics (Issuer) Rivers Tyrell (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 6:58 PM | ADC Therapeutics (Issuer) Kallebo Lisa Michelle (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 6:59 PM | ADC Therapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/19/2023 6:00 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023 3:25 PM | ADC Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2023 6:13 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023 6:16 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023 6:01 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023 6:07 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023 3:14 PM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
07/11/2023 8:05 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023 3:16 PM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023 5:06 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2023 7:00 AM | ADC Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2023 3:08 PM | ADC Therapeutics (Subject) AUVEN THERAPEUTICS HOLDINGS LP (Filed by)
| Form SC 13D/A | |